Biogenoma OÜ

Active Registry code 14849638 OÜ Tartu linn Registered 18 Nov 2019
Compare

Biogenoma OÜ is a OÜ based in Tartu linn, registry code 14849638, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Turnover
—
State taxes
3 498 €
Labour taxes
0 €
Employees
—

Q3 2024 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q3 2024 – Q3 2024
State taxes, € Q3 2024: 3 498 €
01 0002 0003 0004 000Q3 2024 Company: 3 498 €Q3·2401 0002 0003 0004 000Q3 2024 Company: 3 498 €Q3·24
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2024 — 3 498 — —

Financials by year

2020 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
05 00010 00015 00020 00025 0002020 Company: 22 870 € Industry median: 150 €20202021 Company: 22 519 € Industry median: 0 €20212022 Company: 1 583 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: — Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202505 00010 00015 00020 00025 0002020 Company: 22 870 € Industry median: 150 €2021 Company: 22 519 € Industry median: 0 €20212022 Company: 1 583 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: — Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -8 034 € · −384.6% vs 2024 · industry median 0 € · above 10% of the industry
-10 000010 00020 00030 0002020 Company: 21 464 € Industry median: 28 €20202021 Company: 23 808 € Industry median: 1 €20212022 Company: -3 512 € Industry median: 0 €20222023 Company: 8 012 € Industry median: 0 €20232024 Company: -1 658 € Industry median: 0 €20242025 Company: -8 034 € Industry median: 0 €2025-10 000010 00020 00030 0002020 Company: 21 464 € Industry median: 28 €2021 Company: 23 808 € Industry median: 1 €20212022 Company: -3 512 € Industry median: 0 €2023 Company: 8 012 € Industry median: 0 €20232024 Company: -1 658 € Industry median: 0 €2025 Company: -8 034 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2022: -221.9 % · −327.6 pp vs the year before · industry median 17.7 % · above 2% of the industry
-300-200-10001002002020 Company: 93.9 % Industry median: 23.8 %20202021 Company: 105.7 % Industry median: 25.1 %20212022 Company: -221.9 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %2025-300-200-10001002002020 Company: 93.9 % Industry median: 23.8 %2021 Company: 105.7 % Industry median: 25.1 %20212022 Company: -221.9 % Industry median: 17.7 %2023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 33 582 € · −19.5% vs 2024
020 00040 00060 00080 0002020 Company: 23 964 €20202021 Company: 47 772 €20212022 Company: 44 260 €20222023 Company: 60 761 €20232024 Company: 41 714 €20242025 Company: 33 582 €2025020 00040 00060 00080 0002020 Company: 23 964 €2021 Company: 47 772 €20212022 Company: 44 260 €2023 Company: 60 761 €20232024 Company: 41 714 €2025 Company: 33 582 €2025
Equity, € 2025: 33 582 € · −19.3% vs 2024
020 00040 00060 00080 0002020 Company: 23 964 €20202021 Company: 47 772 €20212022 Company: 44 260 €20222023 Company: 60 761 €20232024 Company: 41 616 €20242025 Company: 33 582 €2025020 00040 00060 00080 0002020 Company: 23 964 €2021 Company: 47 772 €20212022 Company: 44 260 €2023 Company: 60 761 €20232024 Company: 41 616 €2025 Company: 33 582 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -8 034 0 33 582 33 582 0
2024 — -1 658 0 41 714 41 616 0
2023 0 8 012 0 60 761 60 761 0
2022 1 583 -3 512 0 44 260 44 260 0
2021 22 519 23 808 0 47 772 47 772 0
2020 22 870 21 464 0 23 964 23 964 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-23.9 %
Net profit / equity
Return on assets (ROA)
-23.9 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 26 Apr 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 14 May 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 17 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 24 May 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 28 Jun 2022 Company’s own e-Äriregister
2020 18 Nov 2019 – 31 Dec 2020 31 May 2021 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Owner in

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main

Rulings 2

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50133179 / 2
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50133179
18 Nov 2019
 First entry In force
18 Nov 2019
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data